Sanjeev Gangwar
About
In The Last Decade
Sanjeev Gangwar
47 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 702
- Oncology 545
- Radiology, Nuclear Medicine and Imaging 352
- Organic Chemistry 331
- Pharmaceutical Science 130
Countries citing papers authored by Sanjeev Gangwar
This map shows the geographic impact of Sanjeev Gangwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeev Gangwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeev Gangwar more than expected).
Fields of papers citing papers by Sanjeev Gangwar
This network shows the impact of papers produced by Sanjeev Gangwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeev Gangwar. The network helps show where Sanjeev Gangwar may publish in the future.
Co-authorship network of co-authors of Sanjeev Gangwar
This figure shows the co-authorship network connecting the top 25 collaborators of Sanjeev Gangwar. A scholar is included among the top collaborators of Sanjeev Gangwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjeev Gangwar. Sanjeev Gangwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 6 | |
| 6 | 30 | |
| 7 | 26 | |
| 8 | 25 | |
| 9 | 5 | |
| 10 | Human antibody conjugates of potential utility for prostate cancer therapy: A comparison of MGBA conjugates with antibodies targeting a cell surface target (prostate-specific membrane antigen) and an extracellular matrix target (Mindin/RG-1) | 1 |
| 11 | 10 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 55 | |
| 15 | CPI-0004Na An extracellularly tumor-activated prodrug of doxorubicin | 1 |
| 16 | 45 | |
| 17 | 35 | |
| 18 | 37 | |
| 19 | 58 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.